advanced search

Welcome: Guest

log in

BioSyntech, Inc. Product Pipeline Analysis

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 34
ISBN Number not applicable
Product Code GMD04844
Buy this product or for assistance call +44 20 7060 7474

Summary

This report is an insightful source for data, analysis and strategic insights into a BioSyntech, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reason to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - Orthopedic Devices
  • 3 BioSyntech, Inc. Pipeline Products
    • 3.1 BioSyntech, Inc. Product Pipeline Analysis
      • 3.1.1 BioSyntech, Inc. Pipeline Products By Equipment Type
      • 3.1.2 BioSyntech, Inc. Pipeline Products By Development Stage
      • 3.1.3 BioSyntech, Inc. Pipeline Products By Therapy Area
      • 3.1.4 BioSyntech, Inc. Pipeline Products By Clinical Trials
      • 3.1.5 BioSyntech, Inc. Pipeline Products By News Summary
    • 3.2 BST-Ossifil
      • 3.2.1 Product Description
      • 3.2.2 Product Status
      • 3.2.3 Product Milestone
    • 3.3 Arthro-BST
      • 3.3.1 Product Description
      • 3.3.2 Product Status
    • 3.4 BST-Disc
      • 3.4.1 Product Description
      • 3.4.2 Product Status
    • 3.5 BST-DermOn
      • 3.5.1 Product Description
      • 3.5.2 Product Status
      • 3.5.3 Clinical Trials
      • 3.5.4 Product Milestone
    • 3.6 BST-CarGel
      • 3.6.1 Product Description
      • 3.6.2 Product Status
      • 3.6.3 Clinical Trials
      • 3.6.4 Product Milestone
  • 4 Business Description
    • 4.1 Business Overview
    • 4.2 Major Products and Services
      • 4.2.1 Overview
  • 5 Competitors
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Company Statement
  • 9 Locations And Subsidiaries
    • 9.1 Head Office
  • 10 Financial Deals Landscape
    • 10.1 Acquisition
      • 10.1.1 Nicholas Piramal Aquires 17.1% Interest In Biosyntech
  • 11 Recent Developments
    • 11.1 Financial Announcements
      • 11.1.1 Nov 12, 2007: BioSyntech Declares Q2 Fiscal 2008 Results
      • 11.1.2 Aug 13, 2007: BioSyntech Reports Q1 Fiscal 2008 Results
      • 11.1.3 Jun 29, 2007: BioSyntech Reports Q4 Fiscal 2007 Results
    • 11.2 Other Significant Developments
      • 11.2.1 Jul 11, 2007: BioSyntech Appoints New Vice President For Regulatory Affairs And Quality
  • 12 Appendix
    • 12.1 Methodology
      • 12.1.1 Coverage
      • 12.1.2 Secondary Research
      • 12.1.3 Primary Research
      • 12.1.4 Expert Panel Validation
    • 12.2 Contact Us
    • 12.3 About Global Markets Direct
    • 12.4 Disclaimer
  • List of Tables
    • Table 1: BioSyntech, Inc.,Key Facts
    • Table 2: BioSyntech, Inc. Pipeline Products by Equipment Type
    • Table 3: BioSyntech, Inc. Pipeline Products By Development Stage
    • Table 4: BioSyntech, Inc. Pipeline Products By Therapy Area
    • Table 5: BioSyntech, Inc. Pipeline Products By Clinical Trials
    • Table 6: BioSyntech, Inc. Pipeline Products By News Summaries
    • Table 7: BioSyntech, Inc., Key Employees,
  • List of Figures
    • Figure 1: BioSyntech, Inc. Pipeline Products By Equipment Type
    • Figure 2: BioSyntech, Inc. Pipeline Products By Equipment Type
    • Figure 3: Global Markets Direct Methodology
Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Product features / use
Scope Expert Insight/Opinion yes
Features Primary Research Data yes

Industry Events